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Dysregulation of smooth muscle contraction is linked to diseases 
such as atherosclerosis, asthma, hypertension, urinary incontinence, 
premature birth and others. The goal of this project is to contribute to our 
understanding of the mechanisms of smooth muscle regulation. Caldesmon 
and fesselin are actin-binding proteins abundant in smooth muscle that 
have multiple binding partners and are well positioned to alter smooth 
muscle contraction.  Because fesselin is a heat-stable proline rich protein 
that has many properties in common with the natively unfolded COOH 
terminal fragment of caldesmon, we sought to determine whether fesselin 
is natively unfolded. We compared fesselin to a known globular protein 
(myosin S1) and the unfolded C-terminal 22 kDa fragment of caldesmon 
(CaD22) using techniques such as gel filtration, intrinsic tryptophan 
fluorescence and circular dichroism. We showed that fesselin is a natively 
unfolded protein. We also investigated the effects of phosphorylation by 
p21-activated kinase 3, PAK, and calmodulin on CaD22.  We found a novel 
regulatory region between the residues 627-642 in the unfolded caldesmon 
C-terminus and identified four minor residues slowly phosphorylated by 
PAK. Phosphorylation of this region alters both the ability of caldesmon to 
inhibit actomyosin ATPase and the interactions between caldesmon and 
Ca2+-calmodulin that may contribute to the overall regulation of 
caldesmon’s activity.   
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CHAPTER I. INTRODUCTION 
Smooth muscle is an involuntary non-striated muscle, found within 
many vital organs, such as arteries and veins, bladder, uterus, male and 
female reproductive tracts, gastrointestinal tract, respiratory tract, the ciliary 
muscle, and iris of the eye.  Malfunction of smooth muscle contraction has 
been implicated to play a role in a large number of diseases, such as 
atherosclerosis, hypertension, asthma, irritable bowel syndrome, urinary 
incontinence and premature birth.  Nonmuscle cells share similarities with 
smooth muscle cells in terms of regulation of contraction.  Nonmuscle cells 
are important in other disorders such as cancer.  Better understanding of 
mechanisms of regulation of smooth muscle contraction may lead to 
therapies for the aforementioned disorders. 
My goal in this thesis is to investigate means of altering smooth 
muscle contraction by focusing on regulatory proteins that are abundant in 
smooth muscle.  Caldesmon and fesselin are natively unfolded actin binding 
proteins that have multiple binding partners (Permyakov et al 2003, 
Khaymina et al 2007).  The biological function of these proteins is not totally 
clear but it is clear that these proteins are excellent targets.   
 
Mechanisms of smooth muscle contraction 
Like any muscle, smooth muscle is made up primarily of two kinds of 
filaments: the thick myosin filaments and the thin actin filaments that contain 
actin and other regulatory proteins (Figure 1A).  Muscle contraction is 
caused by the sliding of myosin and actin filaments over each other.  The 
sliding of the filaments happens when the globular heads protruding from 
myosin filaments attach and interact cyclically with actin filaments to form 
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cross-bridges, moving along actin by a kind of rowing action.  The energy 
for this is provided by the hydrolysis of ATP that produces a conformational 
change in myosin and causes movement.  
 
Regulation of smooth muscle contraction 
Smooth muscle contraction is regulated by changes in both myosin 
and actin filaments.  
Myosin-linked regulation 
Myosin-linked regulation is better characterized and involves calcium-
regulated phosphorylation of myosin.  The myosin heads are made up of 
heavy chains and light protein chains.  In order for cross-bridge cycling to 
occur, myosin light chain kinase (MLCK) must phosphorylate the 20-kDa 
light chain of myosin (Gao et al. 2001), causing myosin to switch from a 
“folded” conformation with very low ATPase activity (10S form) to an 
“extended” active conformation (6S form) and turning on the myosin 
ATPase, as shown in Figure 1B (Sellers and Knight, 2007).  When the 
muscle is stimulated to contract, the intracellular concentration of calcium 
ions is increased.  Calcium binds to calmodulin, and the calcium-calmodulin 
complex activates MLCK allowing myosin to become phosphorylated and 
activated.   
MLCK is the target for phosphorylation by cyclic AMP-dependent 
protein kinase (Conti and Adelstein, 1981), protein kinase C (Ikebe et al. 
1985, Nishikawa et al. 1985) and calmodulin-dependent protein kinase II 
(Hashimoto and Soderling, 1990).  Phosphorylation by any of these kinases 
reduces the affinity of MLCK for calcium-calmodulin thus preventing 
activation of MLCK by calcium-calmodulin.  
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The state of myosin light chain phosphorylation is further regulated by 
MLC phosphatase, which dephosphorylates the myosin light chains and 
inhibits the contraction (Figure 2). (Adelstein and Sellers, 1987).   
Myosin may also be regulated by binding to specific ligands.  Ligands 
could function by changing the size of myosin filaments or by changing the 
conformational state of myosin.  For example, smooth muscle myosin 
filaments are much less stable than skeletal muscle filaments.  ATP easily 
disassembles the dephosphorylated smooth muscle myosin filaments into 
monomers (but not phosphorylated ones).  Caldesmon stabilizes smooth 
myosin thick filaments and cross-links them with actin filaments (Katayama 
et al. 1995). 
Telokin binding to myosin suppresses its folding into the 10S 
conformation keeping myosin in its active 6S state (Masato et al. 1997).  
This seems to be a common mechanism for regulating motor proteins.  
Kinesin-1 is able to fold in a regulatory manner similar to myosin (Hackney 
et al. 1992; Stock et al. 1999).  Proteins JIP-1 and FEZ1, upon binding to 
kinesin-1, are able to activate it (Blasius et al. 2007).  Similarly, myosin-
binding proteins might regulate myosin by altering the equilibrium between 
10S and 6S forms of myosin.  
  
The exact role of caldesmon and fesselin in the regulation of smooth 
muscle contraction is not completely clear yet.   
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Figure 1. A.  Scematic diagram showing the structure of the sarcomere.  B. 
Schematic representation of inactive (10S) and active (6S) myosin forms 
and myosin filaments. C. Schematic representation of G-actin, F-actin and 
acto-myosin interaction.  
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Figure 2. Schematic representation of myosin-linked regulation of smooth 
muscle contraction. 
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Actin-linked regulation 
While myosin phosphorylation is generally thought to be essential for 
smooth muscle contraction to occur, actin-binding proteins may modulate 
contractility by both indirect and direct mechanisms.  
An example of an indirect mechanism is modulation of actin 
polymerization/depolymerization.  Actin alone polymerizes slowly because 
of the rate-limiting process of nucleation.  Proteins such as caldesmon 
(Galazkiewicz et al. 1989), fesselin (Beall and Chalovich, 2001), Arp2/3 
(Pollard et al. 2000) and other accelerate actin assembly from monomeric 
G-actin form into F-actin (Figure 1C).  Caldesmon, tropomyosin and other 
proteins protect actin filaments from severing and disassembly (Dabrowska 
et al. 1996).  
Actin-binding proteins may also directly control the force producing 
interaction between actin and myosin.  Caldesmon, tropomyosin and 
possibly fesselin can alter actin-myosin interactions and regulate 
contraction.  Tropomyosin can occupy different positions on the actin 
surface that may or may not obstruct myosin-binding sites on actin (Xu et 
al. 1999).  The presence of tropomyosin on actin filaments introduces 
cooperativity to the interaction between actin and myosin because 
tropomyosin interacts with seven actin subunits (Greene and Eisenberg 
1980).  Caldesmon and fesselin are also interesting because both of them 
bind to actin (Sobue et al. 1981; Leinweber et al 1999), myosin (Hemric 
and Chalovich, 1988; Schroeter and Chalovich 2005) and calmodulin 
(Sobue et al. 1981; Schroeter and Chalovich, 2004) and inhibit actomyosin 
ATPase activity (Ngai and Walsh, 1984; Schroeter and Chalovich 2005).  
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Both proteins seem to participate in many if not all of the levels of 
regulation of smooth muscle contraction.  
Actin-binding proteins also maintain the unique organization of the 
contractile apparatus in smooth muscle.  Unlike skeletal muscle, in smooth 
muscle no striation is seen under the microscope, giving a “smooth” 
appearance.  Instead, the actin filaments are organized through attachment 
to dense bodies (Heumann, 1970; Uehara et al. 1971) that are the 
equivalent of Z-disks in striated muscle. In smooth muscle, thick and thin 
filaments together with dense bodies form contractile units that are 
connected to each other by intermediate filaments. Figure 3 is a schematic 
illustration demonstrating the suggested arrangements of contractile 
elements in smooth muscle.  Actin filaments are linked to the plasma 
membrane at the dense plaques and within the cell to cytoplasmic dense 
bodies that contain such proteins as alpha-actinin (Lazarides 1976; Fay et 
al. 1983) and fesselin (Renegar et al. 2009). 
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Figure 3. The suggested arrangements of contractile and cytoskeletal 
elements in smooth muscle.  Actin and myosin filaments are depicted as 
long, thin lines or short, thick lines, respectively.  Wavy lines represent 
intermediate filaments.  Dense plaques and dense bodies correspond to 
the closed triangles and the closed circles, respectively. 
  11
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Caldesmon 
Caldesmon is found in smooth muscle cells and also in non-muscle 
cells.  It is of great importance as in smooth muscle it substitutes for 
troponin, one of the main regulators of skeletal muscle contraction (Kamm 
and Stull 1985).  Perhaps the best evidence of an in vivo role of caldesmon 
is increase in caldesmon protein content during pregnancy that contributes 
to the suppression of contractility of pregnant myometrium.  During labor 
the inhibition is reversed to achieve uterine contractions (Li et al. 2003).  
That serves as strong evidence that caldesmon plays a crucial role in 
regulation of muscle contraction and motility.  But the full range of 
caldesmon functions still remains unknown. 
Structure of caldesmon 
Caldesmon has an elongated shape and can be roughly divided into 
three parts (Figure 4).  The N-terminal part houses myosin-binding sites 
and interacts weakly with Ca2+-Calmodulin and actin.  The middle part, also 
known as the “spacer”, contains a highly charged alpha-helical repeating 
sequence (Bryan 1989) and has no clear binding properties.  The spacer is 
present only in h-caldesmon (high molecular mass caldesmon) which is a 
smooth muscle form of caldesmon.  The middle part is deleted in non-
muscle isoform of caldesmon, or l-caldesmon (low molecular mass 
caldesmon) (Bryan and Lee 1991).  The C-terminal part contains almost all 
of the functional properties of the molecule, such as actin, tropomyosin and 
Ca2+-Calmodulin binding (Szpacenko and Dabrowska, 1986; Wang et al. 
1991), inhibition of the actomyosin ATPase activity (Fujii et al 1987) and 
many phosphorylation sites.  The C-terminal region of caldesmon is also 
intrinsically unstructured (Permyakov et al 2003).  The importance of the 
unfolded structure of this region is discussed below.
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Figure 4. Domain structure of smooth-muscle caldesmon.  The 
nomenclature corresponds to chicken h-caldesmon. 
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Regulation by caldesmon 
Caldesmon has many functions in the cell.  It can polymerize actin 
(Galazkiewicz et al. 1989), bundle actin filaments (Bretcher 2004), 
polymerize myosin filaments (Katayama et al. 1995), and inhibit actin-
activated myosin ATPase (Ngai and Walsh, 1984).  For caldesmon to 
regulate actin polymerization and actin activation of myosin ATPase activity 
it is necessary that the effects of caldesmon be variable.  Both calcium-
calmodulin binding and caldesmon phosphorylation are known to influence 
the affinity of caldesmon to its various binding partners and also change the 
activity of caldesmon even when bound to its partners. 
 
Regulation of actin polymerization by caldesmon. 
Caldesmon has a capacity to polymerize G-actin, by stimulating the 
nucleation phase (Galazkiewicz et al. 1989).  When bound to Ca2+-
calmodulin, caldesmon is unable to initiate polymerization of actin 
(Galazkiewicz et al. 1985).  Phosphorylation of caldesmon by MAPK 
(Huang et al. 2003) and cdc2 kinase (Yamashiro et al. 1990) reduces its 
binding to actin and hence might also negatively affect the ability of 
caldesmon to initiate actin polymerization.  It is unclear how important this 
function of caldesmon is in vivo, since many proteins such as Arp2/3 are 
much more potent actin polymerizers (Goley and Welch, 2006).  Arp2/3 
complex has been shown to trigger podosome formation in dynamic cells 
(Yamaguchi et al. 2005).  Caldesmon competes with Arp2/3 for actin 
binding and inhibits podosome formation thus regulating the ability of the 
cell to invade tissues (Morita et al. 2006). 
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Regulation of myosin by caldesmon. 
Caldesmon binding to myosin has been shown to induce the 
formation of myosin filaments under the conditions where myosin alone is 
disassembled, and tether myosin filaments to actin filaments (Katayama et 
al 1995).  Calcium-calmodulin reduces the binding of caldesmon to myosin 
(Ikebe and Reardon, 1988).  Phosphorylation of caldesmon by calmodulin-
dependent kinase II also weakens the binding of caldesmon to myosin 
(Sutherland and Walsh, 1989). 
 
Regulation of actin-activated myosin ATPase by caldesmon. 
Numerous studies have demonstrated that caldesmon acts as an 
inhibitor of the actomyosin ATPase, although there is an ongoing debate in 
the field on what the mechanism of the inhibition is (Chalovich et al. 1998; 
Chalovich et al. 1990; Marston and Redwood, 1992; Alahyan et al 2006).  
In the presence of calcium, calmodulin reverses the inhibititory activity of 
caldesmon toward actin stimulated ATPase activity.  This is a complex 
effect that involves a weakening of its binding to actin and actin-
tropomyosin (Hodgkinson et al 1997).  Some reports show that the ability of 
caldesmon to inhibit ATPase activity is attenuated even when caldesmon 
remains bound to actin (Pritchard and Marston, 1989).  
Phosphorylation of caldesmon by kinases such as MAPK (Redwood 
et al. 1993), cdc2 (Yamakita et al. 1992), PAK (Foster et al. 2000), PKC 
(Vorotnikov et al 1994), Ca2+-calmodulin kinase II (Ngai and Walsh, 1987) 
also releases the inhibition of the ATPase activity.  The phosphorylation 
residues for these kinases have been determined (Figure 5).  
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Effect of Ca2+-calmodulin binding and phosphorylation on the 
conformation of caldesmon. 
The C-terminal region of caldesmon is natively unfolded (Permyakov 
et al. 2003), and its conformation can be easily modified by a ligand binding 
and/or phosphorylation. 
Calmodulin binding was shown to have a distinct structural effect on 
the unfolded C-terminal region of caldesmon.  Binding to calmodulin is 
capable of inducing alpha-helix formation in the synthetic caldesmon 
fragments (Zhou et al. 1997).  Huang et al (2003) observed that when 
caldesmon was bound to actin, both Ca2+-calmodulin binding and 
phosphorylation by MAPK caused a moderate elongation in their 
caldesmon fragment, as detected by Fluorescence Resonance Energy 
Transfer method (FRET).  
No structural data has been reported yet on the phosphorylation of 
caldesmon by PAK kinase. 
 
Kinases that phosphorylate caldesmon in vivo 
There has been an extensive discussion about which kinase is a key 
regulator of caldesmon in vivo and which phosphorylation sites are involved 
in regulation (Gorenne et al. 2004; Redwood et al. 1993; Childs et al. 
1992).  It is possible that several kinases are involved, but currently 
evidence exists for regulation of CaD by phosphorylation in vivo by MAP 
kinase (Adam et al. 1993; D’Angelo et al. 1999), PAK kinase (Eppinga et al. 
2006) and cdc2 kinase (Yamashiro et al. 1991) whereas evidence to 
support the involvement of other kinases in vivo is still scarce.  
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Figure 5. Phosphorylation sites on CaD22.  All phosphorylation sites are in 
bold.  PAK kinase sites are in square brackets.  MAPK sites1, Calmodulin 
kinase II sites2, cdc2 kinase sites3 and PKC sites4 are indicated with 
superscripts as shown.  The tropomyosin-binding region has a single 
underline.  The calmodulin-binding regions have a double underline. The 
residue numbers at the beginning and at the end of the sequence are in 
curly brackets. 
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{563}MKEEIERRRAEAAEKRQKVPEDGVSEEKKPFKCFS3PKGSS2,4LKIEERAEFLNK 
 
SAQKSGMKPAHTTAVVSKIDS2RLEQYTSAVVGNKAAKPAKPAASDLPVPAEGVRN 
 
IK[S]MWEKGNVFSS3PGGTGT3PNKETAGLKVGVS[S]RINEWLTKT3PEGNKS1,3PAP 
 
KPSDLRPGDVSGKRNLWEKQS2,4VEKPAASSSKVTATGKKSETNGLRQFEKEP{771} 
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p21-activated kinase (PAK) 
PAK kinase is emerging as a major regulator of Caldesmon.  First, by 
using an antibody specific to PAK phosphorylation sites on caldesmon PAK 
was shown to phosphorylate caldesmon in vivo (Eppinga et al. 2006).  
Second, constitutively active PAK3 produces Ca2+- independent contraction 
of smooth muscle that coincides with an increase in caldesmon 
phosphorylation (Van Eyk et al. 1998).  Third, PAK kinase appears to be an 
important regulator of caldesmon-mediated actin dynamics (Eppinga et al. 
2006; Dharmawardhane et al, 1997) and cell motility (Jiang et al. 2010) in 
vivo.   
PAK is a serine/threonine protein kinase and a downstream effector 
of Rac and Cdc42 GTPases.  Foster et al. 2000 found that PAK 
phosphorylated caldesmon to a maximum of 2 mol phosphate per mol 
caldesmon within 120 minutes, but the longer incubation times have not 
been investigated.  The phosphorylation sites for PAK were identified as 
Ser672 and Ser702 of chicken gizzard caldesmon.  These sites are 
adjacent to the calmodulin-binding sites, and were less accessible to PAK 
when caldesmon was bound to calmodulin.  PAK phosphorylation 
weakened Ca2+-calmodulin binding to caldesmon by approximately 10-fold.  
Caldesmon phosphorylated by PAK did not significantly change its affinity 
for actin-tropomyosin, only a modest reduction in affinity was reported with 
Kd increase less that 2-fold.  However it was significantly less effective in 
inhibiting actomyosin ATPase activity.  PAK-phosphorylated caldesmon 
inhibited actin-activated myosin S1 ATPase by about 40%, whereas 
unphosphorylated caldesmon was able to inhibit actin-activated myosin S1 
ATPase to about 80% (Foster et al. 2000).  
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 Both phosphorylation and calmodulin binding may occur in smooth 
muscle cells and non muscle cells.  An important question is how these two 
signaling mechanisms work together to alter the effects of caldesmon.   
 
Fesselin 
Fesselin is a protein that was discovered in Dr. Chalovich’s lab in 
1999 by Dr. Barbara Leinweber (Leinweber et al. 1999).  It is a member of 
the synaptopodin family of proteins (Schroeter et al. 2008).  Other 
members of this family include synaptopodin and myopodin, both of which 
are proline-rich actin-associated proteins.  Fesselin shares 96% identity 
with synaptopodin 2 also known as myopodin, and is only 47.4% 
homologous to synaptopodin, with the highest degree of homology residing 
in the C-terminal half on the molecules.   
Synaptopodin 
Synaptopodin is expressed in differentiated kidney glomerular 
podocytes and telencephalic dendrites (Mundel et al. 1997).  The 
expression is restricted to later stages of cellular differentiation.  It can 
directly bind to actin and bundle actin filaments.  Synaptopodin plays a role 
in modulating the actin-based shape and motility of dendritic spines and 
podocyte foot processes.  Synaptopodin-deficient mice lack the dendritic 
spine apparatus and display impaired activity-dependent long-term synaptic 
plasticity (Deller et al. 2003).   
Myopodin 
Myopodin is found at the Z-disks of myoblasts (Weins et al. 2001).  
Myopodin is also able to translocate into the nucleus under stress 
conditions.  Myopodin was proposed to play a dual role as a structural 
protein at the Z-disk and as a regulator protein participating in a signaling 
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pathway between the nucleus and the Z-disk during development and in 
situations of cellular stress.  It was shown that frequent complete or partial 
deletions of the myopodin gene occurred among bladder (Sanchez-
Carbayo et al. 2003) and prostate (Jing et al. 2004) cancer cases.  But the 
exact functions of these proteins are still unknown. 
 
Properties of fesselin 
Unlike other members of the synaptopodin family of proteins, fesselin 
can be readily isolated from heat treated extracts of avian gizzard muscle 
(Leinweber et al. 1999).  Fesselin binds to a variety of proteins, such as 
myosin (Schroeter and Chalovich, 2005), actin (Leinweber et al. 1999), 
alpha-actinin (Pham and Chalovich, 2006) and calmodulin (Schroeter and 
Chalovich, 2004).  Fesselin bundles actin filaments (Leinweber et al, 1999).  
This property of fesselin is very important because it is known that actin 
filaments are usually disrupted in malignant cells (Rao and Li, 2004).  
Fesselin and other actin bundling proteins might provide the basis for 
maintaining cell morphology and preventing metastases.  Fesselin also 
induces actin polymerization (Beall and Chalovich, 2001) and this activity is 
regulated by Ca2+-calmodulin (Schroeter and Chalovich, 2004).  Myosin S1 
competes with fesselin for binding to actin or to actin-tropomyosin and 
fesselin inhibits actin activation of S1 ATPase activity (Schroeter and 
Chalovich, 2005).  It was observed that fesselin is associated with dense 
bodies in smooth muscle tissue (Renegar et al. 2009).  Hence, it is likely 
that fesselin is involved in the regulation of smooth muscle contraction. 
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Similarities between caldesmon and fesselin 
Fesselin shares many features with caldesmon.  Both fesselin and 
caldesmon are actin-binding proteins, their binding affinity is moderate 
(Velaz et al. 1989; Leinweber et al. 1999).  They stimulate actin 
polymerization (Galazkiewicz et al. 1985; Beall and Chalovich, 2001) and 
actin bundle formation (Bretscher, 1984; Leinweber et al. 1999).  Both 
proteins compete with S1 myosin for actin binding and can bind to myosin 
themselves, although the binding occurs in the different regions of myosin 
(Hemric and Chalovich, 1988; Schroeter and Chalovich, 2005).  Fesselin 
and caldesmon also bind to Ca2+-calmodulin (Schroeter and Chalovich, 
2004; Sobue et al. 1981).  Both proteins inhibit actomyosin ATPase activity 
(Ngai and Walsh, 1984; Schroeter and Chalovich, 2005).  However, 
inhibition by caldesmon can be reversed by Ca2+-calmodulin (Szpacenko et 
al. 1985) and phosphorylation (Ngai and Walsh, 1984).  Inhibition by 
fesselin is not regulated by Ca2+-calmodulin or any other regulatory 
mechanisms thus far identified.  It is not clear whether fesselin regulates 
contraction directly.   
Another feature that both proteins share is that both are able to refold 
rapidly since both can be prepared after a heat treatment step.  This and all 
of the above features make sense for caldesmon since it is a natively 
unfolded protein.  The similarity of caldesmon and fesselin made us wonder 
whether fesselin was a natively unfolded protein too.   
 
Natively Unfolded proteins 
Natively Unfolded (or often referred to as intrinsically unstructured or 
disordered) proteins are characterized by lack of stable tertiary structure 
under physiological conditions (Wright and Dyson, 1999; Dunker et al. 
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2002).  It is now known that a large number of proteins encoded by the 
genome contain little or no ordered secondary or tertiary structure under 
physiological conditions.  Interestingly, intrinsic disorder is more prevalent 
in complex organisms.  Eukaryotes contain 35-51% long unstructured 
regions whereas bacteria and archaea contain 7-33% and 9-37%, 
respectively, as calculated by disorder prediction tool PONDR VL-XT 
(Dunker et al. 2000).  The evolutionary persistence of such proteins 
represents strong evidence in the favor of their importance.   
Intrinsically unstructured proteins are of great interest as they appear 
to go against the biochemistry dogma that the folded 3D-structure is 
absolutely essential for biological activity.  Their structures resemble the 
denatured states of ordered proteins, and they exist as an ensemble of 
rapidly interconverting structures (Sickmeier et al. 2007).   
The hallmarks of natively unfolded proteins are larger hydrated 
volumes, little or no secondary structure, increased intramolecular 
flexibility, and unusual responses to environmental changes such as having 
increased structure at high temperatures or at extreme pH values (Uversky, 
2002a).  Natively unfolded proteins may be either coil-like (completely 
unstructured) or premolten globule-like (containing a bit of localized 
structure) (Uversky, 2002b).   
The act of binding often causes regions of natively unfolded proteins 
to adopt different structures upon binding to different targets.  The extent of 
structural changes upon binding ranges from no change, when a protein 
continues to constantly fluctuate between a large number of conformational 
states, to a drastic conformational switch or loss of structure (Tompa et al. 
2005).   
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Special very flexible short elements have been proposed to mediate 
binding (Preformed Structural Elements, PSEs, or Molecular Recognition 
Features, MoRFs).  These elements consist of short regions of intrinsic 
disorder that have strong intrinsic preference for the conformation they 
adopt when bound to their partners (Oldfield et al. 2005).   
The functions of natively unfolded proteins are vast.  Unfolded 
regions often form flexible linkers/spacers between domains that regulate 
the distance between the domains and allow them to move freely relative to 
each other in search for binding partners.  Unstructured proteins have 
relatively low affinity for their binding partners (Dunker et al. 2002).  It 
allows them to quickly detach from another protein, so that a cell can react 
quickly when necessary.  Hence, they can be activators in key cellular 
processes, such as cell division or gene transcription.  Disordered regions 
are preferred sites of protein modifications (Fuxreiter et al. 2007), such as 
phosphorylation or acetylation which are known to act as switches 
activating signaling pathways or targeting proteins for degradation.  
Unfolded regions allow binding to an array of different partners (Uversky, 
2002b), leading to multitasking of the same protein.  Consequently, natively 
unfolded proteins often act as “hubs”, or flexible scaffolds, for protein 
complexes (Dunker et al. 2005).  Unfortunately, natively unfolded proteins 
are often involved in diseases, from cancer to folding diseases, such as 
Alzheimer’s and Parkinson’s (Xie et al. 2007).   
 
Why many actin-binding proteins are natively unfolded? 
Many actin-binding proteins have unstructured regions that may be 
important in regulation.  Unfolded regions of troponin I have been proposed 
to be involved in actin binding and inhibition of muscle contraction 
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(Blumenschein et al. 2006).  CaD22 is largely natively unfolded 
(Permyakov et al. 2003).  Other examples include thymosin β4, WASP, 
dematin, addictin, etc.  The unfolded regions are readily accessible to other 
proteins and provide an easy way to regulate binding to actin by post-
translational modifications such as phosphorylation and by ligand binding.   
It is known that Ca2+-calmodulin binding to a COOH-terminal 
caldesmon fragment induces folding (Permyakov et al. 2003).  Another 
disorder-to-order transition example involves structuring of unfolded region 
of troponin I upon interaction with actin (Blumenschein et al. 2006).  It is 
possible that multiple signals, like phosphorylation and ligand binding (i.e. 
Ca2+-calmodulin) may work synergistically by altering the structure of 
unfolded regions.   
We wished to determine if phosphorylation of natively unfolded actin 
binding proteins causes functional effects and/or structural changes similar 
to those observed by ligand binding.  One of the proteins we chose to look 
at is a natively unfolded caldesmon because in smooth muscle it 
substitutes for troponin, one of the main regulators of skeletal muscle 
contraction, hence it might be of great importance in regulation.  Another 
protein is fesselin that shares many features with caldesmon, as reviewed 
above, and may be an anti-oncogene in the cell.  
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CHAPTER II. FESSELIN IS A NATIVELY UNFOLDED PROTEIN 
Because fesselin shares many features with the natively unfolded C-
terminal region of caldesmon we wanted to establish whether fesselin, like 
caldesmon, belongs to the family of natively unfolded proteins.   
 
Results 
Primary Structure Analysis.  
We used several alrorithms to predict the fraction of disorder of 
fesselin from turkey meleagris gallopavo {GenBank: ABU55374.1}.  The 
program PONDR (Combet et al. 2000) predicted the maximum amount of 
random coil (69.7%), while PreLink (Coeytaux et al. 2005), GlobPlot 
(Linding et al. 2003) and FoldUnfold (Galzitskaya et al. 2006) predicted 45-
49% disorder. 
All of the above algorithms predicted that fesselin contains unfolded 
regions interspersed with short structured regions (Fig. 6A). Further 
analysis of this sequence with PONDR predicted that the structure is 64-
73% random coil, 16-25% alpha helix and 6-10% extended strand. 
Natively unfolded proteins often have a greater net charge and a 
lower fraction of hydrophobic residues than folded proteins. Folded and 
unfolded proteins can often be distinguished by a charge-hydrophobicity 
plot (Uversky 2002a). Fig. 6B is a plot of the net charge versus the 
hydrophobicity for folded and natively unfolded proteins. The 
hydrophobicity and net charge of fesselin from turkey meleagris gallopavo 
were calculated using PONDR. Avian fesselin is at the border between 
unfolded and folded proteins. With these additional clues that fesselin could 
be natively unfolded, we examined physical properties of the protein 
fesselin that distinguish folded from unfolded proteins.  
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Analysis of the Stokes Radii of fesselin and Caldesmon22 by gel filtration 
chromatography and laser light scattering.  
Unfolded proteins have larger stokes radii than folded proteins and 
therefore elute from gel filtration columns earlier than predicted from their 
masses. Figure 7A shows a plot of log (molecular weight) vs. elution time 
for a series of standard proteins. Myosin S1 falls on that standard curve as 
expected for a globular protein. However, both fesselin and Cad22 eluted 
earlier than expected for their molecular masses. We monitored molecular 
weight by light scattering to ensure that this was a real phenomenon. The 
molecular masses of fesselin and caldesmon obtained by light scattering 
were close to the expected masses, 73 kDa and 24 kDa, respectively. The 
apparent molecular masses of fesselin and Cad22 were 159 kDa and 115 
kDa, respectively. These values correspond to Stokes radii of 5.3 nm and 
4.6 nm, respectively. The expected Stokes radii were 4 nm for fesselin and 
2 nm for Cad22. Fesselin has a Stokes radius that is 1.3x that expected for 
its molecular weight. Cad22 has a Stokes radius that is 2.4x its expected 
value. Therefore both fesselin and Cad22 have open structures. 
Figure 7B shows plots of log(Rs) vs. log(M) for different 
conformational states of globular and natively unfolded proteins. 
Hydrodynamic data for fesselin were overlaid with these plots. Fesselin fell 
on the curve corresponding to premolten globule-like proteins. The data 
used to plot dependencies were taken from published results (Uversky 
2002a; Tcherkasskaya et al. 2001). 
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FIGURE 6. A. Analysis using PONDR VLXT predictor. Fesselin is predicted 
to be largely unfolded, with several small structured regions. The location of 
the tryptophan residues within the sequence of fesselin is indicated by 
open circles.  B. Charge-hydrophobicity plot for natively folded (black 
squares) and natively unfolded (white circles) proteins (Uversky 2002a). 
Superimposed are the data for fesselin (white hexagon). Fesselin falls on 
the border (solid line) between natively unfolded and natively folded 
proteins. 
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FIGURE 7A. Both fesselin (solid circle) and Cad22 (solid square) are 
eluted earlier than expected for their molecular weights. The arrow 
indicates data for S1. B. Dependencies of Stokes radii (Rs) on molecular 
weight (M) for native globular proteins (squares), molten globules (circles), 
premolten globules (triangles), 6M guanidine HCl-unfolded proteins 
(diamonds), premolten globule-like state of natively unfolded proteins (filled 
triangles), and coil-like proteins (solid diamonds). Fesselin is shown as a 
white hexagon. The data used to plot the dependencies are taken from 
published results (Uversky 2002a; Tcherkasskaya et al. 2001). 
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Analysis of intrinsic tryptophan fluorescence of S1, Cad22 and 
fesselin.  
Another measure of the packing density of a protein is the exposure 
of its tryptophan residues to the solution. Tryptophan residues are normally 
buried in folded proteins. This burial shifts the fluorescence maximum from 
about 350 nm (typical for L-tryptophan in water solution) to about 335 nm 
as a result of shielding of tryptophan residues from the aqueous phase by 
the protein (Lakowicz 1983) Exposure of the tryptophan residues upon 
unfolding typically leads to an increase in quenching due to better 
accessibility of the fluorophores to quencher. The location of the tryptophan 
residues within the fesselin sequence is shown in Figure 6A. 
Figure 8A shows that myosin S1 has a tryptophan fluorescence 
spectrum typical for a folded protein. The fluorescence maximum was 
centered at 334 nm, as expected in the case when tryptophan residues are 
buried inside the protein. Addition of sufficient guanidine hydrochloride to 
denature S1 led to a reduction in the intensity and a shift to a longer 
wavelength, 346 nm (Fig. 8A). 
In contrast, both Cad22 (Fig. 8B), and fesselin (Fig. 8C) had spectra 
under native conditions that were typical of proteins with exposed 
tryptophan residues with maxima at 344 nm. Furthermore, the addition of 
6M guanidine HCl had little effect on the spectra. The lack of effect of a 
denaturant confirms that the tryptophan residues were already exposed in 
both cases. 
Exposure of the tryptophan residues was further investigated by the 
sensitivity of the spectra to a neutral quencher, acrylamide. Figure 9 shows 
the fluorescence intensity as a function of acrylamide concentration for S1, 
fesselin and Cad22. In the absence of a denaturant, S1 exhibited a linear 
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decrease in tryptophan fluorescence intensity with increasing acrylamide 
concentration. Upon addition of 6M guanidine HCl, the sensitivity to the 
quencher increased indicating increased exposure of tryptophan residues 
to the solvent. The non-linear relationship between the fluorescence and 
the quencher concentration could be due to the presence of both dynamic 
and static quenching. 
The fluorescence intensities of tryptophan residues of both fesselin 
and Cad22 were more sensitive to the quencher in the absence of 
denaturant than was S1. This indicates a greater exposure of tryptophan 
residues of fesselin and Cad22 to the solvent. Furthermore, the curves 
obtained for fesselin and Cad22 were unchanged by the denaturant 
indicating that the structures are largely the same in the absence and 
presence of a denaturant. The upward curvature of the plot suggested 
dynamic and static quenching. The quenching constants were the same in 
the presence and absence of guanidine HCl suggesting that fesselin and 
Cad22 are unfolded under normal conditions (Fig. 9). 
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FIGURE 8. Effect of denaturatants on the tryptophan fluorescence for 
myosin S1 (A), Cad22 (B) and fesselin (C). Spectra were collected at 250C, 
either under native conditions (10 mM MOPS, 0.1 M KCl, 0.5 mM EDTA, 0.5 
mM EGTA, pH 7.2) or in the same buffer containing 6 M guanidine HCl. 
Native spectra and spectra in the presence of 6 M guanidine HCl correspond 
to solid and dashed lines, respectively.  
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FIGURE 9. Stern-Volmer analyses of quenching of intrinsic tryptophan 
fluorescence of S1 (A), the 22 kDa caldesmon fragment (B) and fesselin 
(C). Data were collected at 25oC either under native conditions,10 mM 
MOPS, 0.1 M KCl, 0.5mM EDTA, 0.5 mM EGTA, pH 7.2 (circles) or in the 
same buffer with 6 M guanidine HCl (squares). Solid lines correspond to 
the best fit of the equation 1: F0/F = 1 + (KD + KS)*[Q] + KD*KS* [Q]2, where 
F0 and F are the fluorescence intensities in the absence and presence of 
quencher, respectively; KD and KS are the dynamic and static Stern-Volmer 
quenching constants, Q is the concentration of the quencher. The values of 
Kd and Ks determined for each experiment as follows: S1: Ks=0, Kd=4.43 
M-1 (native conditions), Ks=1.54 M-1 and Kd=5.8 M-1 (guanidine HCl). CaD 
fragment: Ks=Kd=3.8 M-1 (native conditions), Ks=Kd=3.9 M-1 (guanidine 
HCl). Fesselin: Ks=Kd=4.6 M-1 (native conditions), Ks=Kd=4.4 M-1 
(guanidine HCl). 
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Analysis of calmodulin binding to Cad22 and fesselin.  
Both fesselin (Schroeter and Chalovich, 2005) and caldesmon 
(Sobue et al. 1981) bind to calmodulin. Calmodulin has already been 
shown to induce folding of Cad22 (Permyakov et al. 2003; Zhou et al. 
1997) We examined the sensitivity of fesselin and Cad22 to acrylamide 
quenching in the presence of calmodulin to determine if calmodulin induces 
structure in fesselin as well. Calmodulin had a large effect on the 
quenching curve of Cad22 (Fig. 10A). The sensitivity of Cad22 to 
acrylamide was decreased when Cad22 was bound to calmodulin 
(squares). The quenching curve of fesselin was similarly affected by 
calmodulin binding but to a lesser degree. Figure 10B shows that the 
tryptophan residues of fesselin were protected by calmodulin. 
The smaller effect seen with fesselin was likely the result of using 
intact fesselin rather than a calmodulin binding fragment of fesselin. We 
attempted to express a calmodulin binding domain of fesselin to further 
investigate possible induction of structure. That effort failed as described in 
Appendix 1.
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FIGURE 10. Calmodulin binding to the 22 kDa caldesmon fragment (A) and 
to fesselin (B) protects the tryptophan residues from acrylamide quenching. 
Data are shown for the free protein (circles) and for the protein-calmodulin 
complex (squares). The conditions were 10 mM MOPS pH 7.2, 0.1 M KCl, 
1 mM CaCl2, at 25OC. In all cases the curves exhibited complex quenching 
patterns that could be caused by both static and dynamic quenching. The 
following values of Kd and Ks were recovered from the best fit of Equation 
1: Fesselin: Ks=Kd=4.5 M-1; Fesselin-calmodulin: Ks=Kd=3.8 M-1; CaD 
fragment: Ks=Kd=4.1 M-1; CaD fragment-calmodulin: Ks=Kd=2.2 M-1. 
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Analysis of environmental effects on fesselin secondary structure by CD.  
Far-UV CD spectroscopy is useful for determining the types of 
secondary structure present in polypeptide chains. Alpha-helices give 
characteristic negative peaks near 208 nm and 222 nm and a positive peak 
around 192 nm, β-sheets yield a negative peak at about 215 nm and a 
positive peak near 198 nm, and random coils are characterized by a 
negative peak near 195 nm and by weak ellipticity at 222 nm (Adler et al. 
1973). 
The CD spectrum of fesselin at 5oC was similar to that of a random 
coil but the shoulder at 220 nm suggested the presence of some folded 
secondary structure (Fig 11A). CD spectra of fesselin were recorded at a 
series of temperatures (Fig 11A-C). With increasing temperature the 
spectra showed an increase in secondary structure as seen by a less 
negative peak at 200 nm and appearance of some ellipticity at 220 nm. The 
greatest amount of structure was seen at 85oC. These temperature effects 
were totally reversible. It is also noteworthy that the spectra exhibited an 
isodichroic point near 210 nm, indicating that the temperature-induced 
transition is two state, from an unfolded structure to a specific more-folded 
(albeit as yet undetermined) structure. 
 The CD spectrum of fesselin was insensitive to changes of pH over 
the range from pH 1.5 to 11.5 (Fig. 11D). The spectra of fesselin were 
dominated by random coil at all values of pH, although the gain of structure 
at extreme pH values has been reported for some natively unfolded 
proteins. This might be explained by the fact that fesselin lacks high net 
charge typical of many unstructured proteins. High proline content might be 
the major factor keeping fesselin from folding. 
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FIGURE 11. Environmental effects on fesselin secondary structure. A. 
Effect of temperature on the structural properties of fesselin. CD spectra of 
fesselin were measured at increasing temperatures: 5, 15, 25, 35, 45, 55, 
65, 75 and 85ºC (in order of the decrease in negative [Θ]200 value, as 
indicated by the arrow) and cooled down to 5ºC. B & C. CD at 222 nm (B) 
and at 220 nm (C) are reversible with heating (solid lines) and cooling 
(dashed lines) of fesselin. D. CD spectra of fesselin measured at pH 1.5, 3, 
5, 6, 7, 8, 11.5. 
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Discussion 
 Judging from the Stokes radius, the effect of denaturants, the 
exposure of tryptophan residues to the bulk solvent, the temperature 
dependence of CD and the insensitivity of CD to changes in pH, fesselin is 
natively unfolded. 
 Several structure predictors showed that fesselin (Schroeter et al. 
2008) has a predicted structure that consists of unfolded regions 
interspersed with short structured regions. Such patterns are typical of 
natively unfolded proteins. These structured regions are known to be 
important in specific ligand binding in some cases (Mohan et al. 2006; 
Fuxreiter et al. 2004). The presence of numerous discrete folded regions 
may account for the ability of fesselin to bind to several ligand proteins. 
 An analysis of the mean net charge and mean hydrophobicity 
predicts that avian fesselin falls on the border of unfolded and folded 
proteins. Fesselin lacks the high net charge at neutral pH typical of many 
natively unfolded proteins. A high value of net charge at neutral pH causes 
charge-charge repulsion that prevents natively unfolded proteins from 
folding (Uversky et al. 2000). The lack of charge repulsion in fesselin 
explains the insensitivity of the secondary structure of fesselin to changes 
in pH (Fig. 11D). Fesselin may be unfolded because of the elevated 
frequency of proline residues in the primary structure. The content of 
proline residues in the sequence of fesselin is 11.1% while typical globular 
proteins have a proline content of 4.6% (Tompa, 2002) 
 The Stokes radius of fesselin was found to be 5.3 nm whereas the 
expected Stokes radius was about 4 nm. The Stokes radii of natively 
unfolded proteins are typically larger than predicted for globular proteins of 
the same molecular weight, that is, unfolded proteins are less compact than 
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folded proteins. The relationship between Stokes radius and molecular 
weight of fesselin suggests that fesselin might possess a premolten 
globule-like conformation. The small amount of secondary structure that we 
observed by CD spectroscopy is consistent with that conclusion. This 
residual secondary structure might allow for more efficient folding induced 
by a binding partner. 
 Fesselin contains 7 tryptophan residues. 5 residues are found in the 
disordered regions predicted by the program PONDR (Fig. 6A), and 2 
tryptophan residues correlate with the structured units suggested by the 
Fig. 6A. We observed that the wavelength of the emission maximum of the 
tryptophan residues in fesselin was close to that of an exposed tryptophan 
residue. Furthermore, the spectra of fesselin and Cad22 did not change 
appreciably in the presence of a strong denaturant (6M guanidine HCl) 
indicating that in both cases most of the tryptophan residues were exposed 
to solvent. In contrast, the emission spectrum of myosin S1, a known folded 
protein, was very sensitive to guanidine HCl. 
When fesselin was bound to calmodulin, the neutral quencher 
acrylamide was not able to quench tryptophan fluorescence as effectively 
as in the case of fesselin alone. This protection could be due to a direct 
shielding of tryptophan residues by calmodulin or to folding of fesselin upon 
calmodulin binding. Formation of secondary structure upon ligand binding 
is known to occur for a number of natively unfolded proteins (Mohan et al. 
2006; Oldfield et al. 2005; Bourhis et al. 2004). Molecular recognition 
elements (MoREs) are able to undergo a disorder-to-order transition that is 
stabilized by binding to their partner protein or nucleic acid (Mohan et al. 
2006; Fuxreiter et al. 2004). We suggest that calmodulin binds to a MoRE 
of fesselin causing this region to undergo local folding.  
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Calmodulin had a larger protective effect for Cad22 than for fesselin. 
This is probably due to the difference in size of fesselin and Cad22. The 
calmodulin-induced change is probably associated not with the induction of 
structure at the level of the whole protein, but with the local folding of the 
region directly involved in binding (Moham et al. 2006; Fuxreiter et al. 2004; 
Oldfield et al. 2005). Thus the formation of a small folded unit will have a 
larger impact on a small protein than on a large protein. 
 Natively unfolded proteins have little secondary structure, but the 
secondary structure often increases upon heating (Uversky 2002a). At low 
temperatures fesselin has a typical random coil CD spectrum with some 
residual secondary structure seen as a small negative shoulder at 220 nm. 
As the temperature was increased to 85oC this shoulder at 220 nm 
increased slightly and the peak at 200 nm decreased with the spectra 
crossing at an isodichroic point (near 210 nm). These changes indicated a 
transition to a more folded structure at elevated temperatures. The 
structural changes induced by heating were completely reversible, implying 
that the unfolded and more-folded structures were in equilibrium. This 
effect of elevated temperature may be due to increased hydrophobic 
interactions that are important for folding (Uversky 2002a). 
 A lot of effort has been made to determine the relationship between 
intrinsic disorder and biological processes, hence knowledge that fesselin 
is natively unfolded can be used as a guide for understanding the function 
of fesselin.  
Many proteins involved in cell signaling and molecular recognition are 
disordered; that enables rapid binding to different targets without sacrificing 
specificity. For example, the C-terminal domain of C-Fos is intrinsically 
disordered, nevertheless it is biologically active (Campbell et al, 2000). This 
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domain activates transcription by interacting with many transcription 
factors, such as TBP, TFIIH, CBP and Smad3 (Bannister and Kouzarides, 
1995; Zhang et al, 1998). Binding to multiple partners is possible due to the 
conformational freedom of this domain. p53 (Bell et al, 2002) and CREB 
(Zor et al. 2002) are among other examples of such proteins.  
Post-translational modifications often occur in disordered regions, 
probably due to the ability of such regions to fold onto the surface of 
enzymes (Dunker et al, 2002). For example, c-src kinase is regulated via 
tyrosine phosphorylation in its activation loop. When the kinase is inactive 
the loop is ordered, but it becomes flexible upon kinase activation exposing 
tyrosine for phosphorylation (Xu et al, 1999b). The majority of 
phosphorylation sites in p53 are located in its disordered parts (Ayed et al, 
2001).  
Due to their open structures and ability to interact with multiple 
partners some natively unfolded proteins regulate the localization of other 
proteins in the cell by assembling complexes of proteins. Disorder-to-order 
transition upon binding usually results in formation of tight overall 
complexes. For example, a scaffold protein caskin has a long unfolded C-
terminal domain (Balazs et al, 2009) that can bind to 9 other proteins, and 
the complex is presumably involved in the assembly of post-synaptic 
densities.  
 
It is possible that fesselin acts as a potential assembler in smooth 
muscle cells, because it is localized in the center of actin organization, 
dense bodies (Renegar et al. 2008), polymerizes and bundles actin (Beall 
and Chalovich 2001; Schroeter and Chalovich, 2004) and interacts with 
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other proteins present in dense bodies, such as alpha-actinin (Pham and 
Chalovich, 2006).  
It has been reported that myopodin shuttles between the nucleus and 
the Z-disks of myocytes depending on its differentiation stage and stress 
conditions (Weins et al, 2001), and its subcellular localization is controlled 
by phosphorylation (Faul et al. 2007). Mounting evidence suggests that Z-
disks might be actively involved in signaling. Z-disks might function not only 
by passively transmitting force within myofilaments, but also as a network 
that can sense changes in mechanical load and communicate the 
immediate needs of the cell to the nucleus, modifying the pattern of gene 
expression (Epstein and Davis, 2003; Pyle and Solaro, 2004). Hence it is 
possible that myopodin/fesselin are involved in signal transduction in the 
cell. 
Fesselin is another example of natively disordered actin-binding 
proteins, such as caldesmon (Permyakov et al. 2003), thymosin β4 (Czisch 
et al. 1993), and WASP (Kim et al. 2000). Disorder is thought to correlate 
strongly with cytoskeletal functions (Xie et al. 2007). The flexible structures 
of natively unfolded proteins may facilitate actin recognition of a variety of 
molecular targets, thus explaining the large number of functions attributed 
to actin.  
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CHAPTER III. PHOSPHORYLATION OF CALDESMON AT SITES 
BETWEEN RESIDUES 627-642 ATTENUATES INHIBITORY ACTIVITY 
AND CONTRIBUTES TO A REDUCTION IN CA2+-CALMODULIN 
AFFINITY. 
We suggested that Ca2+-calmodulin causes the region of fesselin 
involved in binding to undergo disorder-to-order transition. This idea is 
supported by our experiments with the whole fesselin molecule, in which 
we observed a possible increase in the amount of secondary structure of 
fesselin upon calmodulin binding. Since these conformational changes 
usually occur locally and the major part of the fesselin molecule probably 
remains unfolded when Ca2+-calmodulin is bound, studying this induced 
folding presents a challenge. To overcome this difficulty we tried to clone 
and express a fragment of fesselin that contains Ca2+-calmodulin binding 
sites, because the formation of a small folded unit is easier to observe 
within a small protein than within a large protein. We attempted to express 
cDNA coding for 10 kD fragment of fesselin containing Ca2+-calmodulin 
binding sites, either alone or as a fusion with GST or intein (Appendix 1). In 
no case did we observe a detectable amount of expression. It is possible 
that the 10 kD fesselin fragment is highly disordered and hence subject to 
rapid proteolytic degradation in the cell. 
Since our attempt to make a fragment of fesselin failed, we wanted to 
use a C-terminal fragment of caldesmon to determine whether 
phosphorylation of natively unfolded actin binding proteins causes 
structural and functional changes similar to those observed by ligand 
binding.  
Caldesmon, another natively unfolded protein that is regulated by 
Ca2+-calmodulin and phosphorylation, is an important regulator of smooth 
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muscle contraction and shares numerous functions with fesselin, as 
reviewed in the Introduction. Ca2+-calmodulin binding causes formation of a 
local structure in the unfolded C-terminal region of caldesmon (Permyakov 
et al. 2003; Zhou et al; 1997). Although it is known that phosphorylation 
functionally affects caldesmon in a way similar to Ca2+-calmodulin, i.e. both 
reduce its actin-binding affinity and release the inhibition of the actomyosin 
ATPase activity by caldesmon, very little is known about the effect of 
phosphorylation on the structure of caldesmon. It might be possible that 
phosphorylation of caldesmon causes a conformational change that mimics 
its Ca2+-calmodulin binding state.   
There are examples of other natively unfolded proteins that increase 
their secondary structure upon phosphorylation. For example, a protein Tau 
that is related to Alzheimer’s disease is hyperphosphorylated in its 
pathological state. Its ability to form alpha-helices, which has been 
associated with pathological protein aggregation, increases with 
phosphorylation (Mendieta et al. 2005).   
We wanted to explore the possibility that phosphorylation of  the 
natively unfolded caldesmon C-terminus causes structural changes similar 
to those observed upon Ca2+-calmodulin binding.  
We used CaD22 phosphorylated with PAK as a model because (i) 
PAK was shown to phosphorylate caldesmon in vivo (Eppinga et al. 2006), 
(ii) constitutively active PAK3 produces Ca2+- independent contraction of 
smooth muscle that coincides with an increase in caldesmon 
phosphorylation (Van Eyk et al. 1998) and (iii) PAK appears to be an 
important regulator of caldesmon-mediated actin dynamics (Eppinga et al. 
2006; Dharmawardhane et al, 1997) and cell motility (Jiang et al. 2010) in 
vivo.  
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Results 
Effect of PAK phosphorylation and calmodulin binding on the amount 
of secondary structure in caldesmon.  
Far UV CD spectroscopy was used to monitor the amount of 
secondary structure in CaD22. Figure 12A represents the CD spectra of 
CaD22 before and after incubation with PAK. No appreciable difference 
was recorded between the unphosphorylated and phosphorylated CaD22. 
This suggests that phosphorylation of caldesmon by PAK does not cause 
any significant changes in the secondary structure of caldesmon, unlike 
Ca2+-calmodulin binding, as described by Permyakov et al. 2003. As a 
control we reproduced the CD spectra for CaD22, calmodulin and CaD22-
calmodulin complex as described in Permyakov et al 2003 (Figure 12B). 
We compared the measured and the calculated spectra for CaD22 alone 
and in complex with calmodulin. If calmodulin binding does not induce any 
structural changes in caldesmon then the measured spectrum should be 
equal to the calculated one. However, if calmodulin binding does induce 
structural changes then the measured and the calculated spectra will be 
different. Figure 12B shows that the experimentally measured spectrum of 
CaD22 alone (solid line) is different from the calculated spectrum of CaD22 
when bound to calmodulin (dashed-dotted line), as seen by Permyakov et 
al 2003. CaD22 alone produces a spectrum typical of natively unfolded 
proteins with an intense negative peak in the 200 nm region and a weak 
signal in the vicinity of 222 nm. The calculated spectrum for CaD22 bound 
to calmodulin shows less intense minimum at 200 nm and increased 
negative intensity near 222 nm, suggesting the increase in the ordered 
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secondary structure. Hence PAK phosphorylation and Ca2+-calmodulin 
binding to CaD22 do not cause similar structural changes in caldesmon. 
 To ensure that CaD22 was indeed phosphorylated by PAK we 
compared migration of unphosphorylated and phosphorylated CaD22 on 
isoelectric focusing gels (Figure 13). PAK kinase was shown to 
phosphorylate caldesmon at two sites, Ser 672 and Ser 702 and 
phosphorylation was complete within the course of 1.5-2 hours. (Foster et 
al. 2000).  Figure 13A shows untreated CaD22 (lane 1) and CaD22 that 
was treated with PAK for 1.5 hours (lane 2) and 20 hours (lane 3).  
Untreated CaD22 focused as 2 closely spaced bands. The number of 
bands with lower isoelectric points increased after 1.5 hours of incubation 
with PAK, as expected. Surprisingly, we observed  a further increase in the 
number of bands with lower isoelectric points after 20 hours of incubation. 
SDS gels showed that the CaD22WT remained intact during those periods 
of incubation (Figure 13B).  These time dependent shifts raised the 
possibility that more than 2 sites within CaD22 became phosphorylated. 
We wanted to investigate the effects of the additional phosphorylation on 
the properties of caldesmon. 
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Figure 12. PAK phosphorylation does not significantly affect the 
secondary structure of caldesmon. A. Far UV CD spectra of CaD22 
before (solid line) and after (dashed line) phosphorylation by PAK. B. Far 
UV CD spectra of CaD22 (solid line), calmodulin (dashed-double dotted 
line) and CaD22-calmodulin complex (dotted line). The molar ratio of 
CaD22:calmodulin was 1:1. Spectrum of CaD22 bound to calmodulin was 
calculated as ((CaD22-CaM)-(1/2CaM)) and shown as a dashed-dotted 
line. The conditions were 50 mM potassium chloride, 2 mM sodium 
phosphate and 2 mM CaCl2 at 20oC. M.R.E. – mean residue ellipticity. 
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Figure 13. PAK phosphorylation changes charge in CaD22. 
 A. Non-equilibrium isoelectric focusing gel. Lane 1: CaD22WT, Lane 2: 
CaD22WT PAK phosphorylated for 1.5 hours, Lane 3: CaD22WT after PAK 
phosphorylation for 20 hours. B. SDS-gel.  Lane 1: CaD22WT, Lane 2: 
CaD22WT after PAK phosphorylation for 20 hours. 
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No-phosphorylation and constitutive phosphorylation-mimicking 
mutants.   
To study the effects of additional phosphorylation of CaD22 by PAK 
we modified the two major phosphorylation sites, Ser672 and Ser702 of 
chicken gizzard CaD22.  Serine to alanine substitutions were made to 
mimic the non-phosphorylated state (CaD22AA). The phosphorylated state 
was mimicked by replacing both serine residues with aspartic acid residues 
(CaD22DD).  The presence of the correct mutations was verified by 
sequencing both plasmids.  For wild type CaD22 the observed mass 
(22625 Da) was consistent with the calculated mass (22630 Da).  Similar 
agreement was obtained for the observed mass (22690 Da) and calculated 
mass (22686 Da) of CaD22DD.  In both cases the observed masses were 
within 0.02% of the calculated ones.  
The presence of additional charges in the CaD22DD mutant was 
verified by nonequilibrium isoelectric focusing gels.  Theoretical pI values 
for CaD22 and CaD22DD are 9.7 and 9.56, respectively. Figure 14A shows 
that CaD22DD (lane 2) migrated less toward the cathode than wild type 
CaD22 (lane 1).  The migration of the AA mutant was identical to the wild 
type (not shown).  CaD22WT, CaD2AA and CaD22DD migrated similarly 
on SDS gels (data not shown). 
 
Analysis of the time course of CaD22 phosphorylation by PAK by 
isoelectric focusing gels. 
To test the possibility that PAK phosphorylates residues other than 
Ser672 and Ser 702 on caldesmon, the two types of CaD22 that lacked 
phosphorylation sites at 672 and 702 were subjected to PAK treatment.  
Fig. 14B shows CaD22DD before (lane 3) and after (lane 4) a 20 hour 
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incubation with PAK.  Fig. 14C shows CaD22AA before (lane 5) and after 
(lane 6) a 20 hour incubation with PAK.  The additional acidic bands 
present in both cases indicated that additional phosphorylation sites were 
present. 
 
Analysis of the time course of CaD22 phosphorylation by PAK by 
measuring the incorporation of 32P into caldesmon. 
Figure 15 shows the time courses of phosphorylation of wild type and 
CaD22AA by PAK.  CaD22WT was phosphorylated to give 2 mol 
phosphate/mol CaD22 (open circles) in the first phase.  Upon continued 
incubation the caldesmon fragment slowly incorporated additional 
phosphate residues giving 3.3 mol phosphate/mol CaD22 after 23 hours. 
When the study was repeated with CaD22AA having the two major PAK 
sites blocked, the first phosphorylation phase was absent, but the 
additional slow phosphorylation still occurred (solid circles).   
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Figure 14. Non-equilibrium isoelectric focusing showing charge 
changes in CaD22 following PAK phosphorylation.  (A) Lane 1: 
CaD22WT, Lane 2: CaD22DD. (B) Lane 3: CaD22DD, Lane 4: CaD22DD 
after incubation for 20 hours with PAK.  (C) Lane 5: CaD22AA, Lane 6: 
CaD22AA after incubation for 20 hours with PAK. 
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Figure 15. Two sets of sites on CaD22 were phosphorylated by 
extended treatment with PAK. The phosphorylation time course was 
followed by 32Pi incorporation at 25°C  in a buffer containing 20 mM Tris-HCl 
pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT and 1 mM 32P-ATP (4x105 
cpm/nmol). Both CaD22WT (open circles) and CaDAA (solid circles) are 
shown. Phosphorylation at sites other than Ser672 and Ser702 is evident in 
both cases.  
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Effect of phosphorylation at the major and minor sites of CaD22 on 
Ca2+-calmodulin binding. 
The effect of phosphorylation at the major and minor sites of CaD22 
on Ca2+-calmodulin binding was determined with intrinsic tryptophan 
fluorescence measurements.  Figure 16 compares Ca2+-calmodulin binding 
isotherms for CaD22 that was non-phosphorylated, phosphorylated only at 
the major sites and phosphorylated at both the major and minor sites.  
Phosphorylation at the major sites reduced the affinity of CaD22 for Ca2+-
calmodulin from Kd=0.11 µM (open circles) to Kd=0.8 µM (dotted circles). 
More extensive phosphorylation (solid circles) caused further reduction in 
the binding affinity, to about 4.0 µM. An examination of the 95% confidence 
limits shows that the three binding curves are statistically different. 
The study of Figure 16 was repeated with mutants of CaD22 lacking 
the major phosphorylation sites.  CaD22AA lacks charges at the major sites 
and cannot be phosphorylated at these sites. Figure 17A compares 
unphosphorylated CaD22AA with CaD22AA that was treated with PAK for 
up to 20 hours.  Although such treatment caused phosphorylation at the 
minor sites the affinity for Ca2+-calmodulin was unaffected.  The affinities of 
both phosphorylated and non-phosphorylated CaD22AA for Ca2+-
calmodulin were similar to that of the wild type CaD22 (Fig. 17A). That is, 
curves for both phosphorylated and non-phosphorylated CaD22AA fell 
within the 95% confidence interval for the wild type curve. On the other 
hand, CaD22DD bound weaker to Ca2+-calmodulin than CaD22WT, but not 
as weak as CaD22-PAK.  That is, the 95% confidence intervals did not 
overlap.   The curve for phosphorylated CaD22 from Fig. 16 is shown for 
comparison (dashed curve).   
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CaD22DD has negative charges at the major sites and incubation 
with PAK led to phosphorylation of only the minor sites.  Treatment of 
CaD22DD with PAK caused further reduction in the binding affinity, 
bringing it close to that of the phosphorylated wild type CaD22 (Fig. 17B).  
The results of Fig. 17 suggest that phosphorylation of caldesmon at 
the unknown sites affects Ca2+-calmodulin binding only if the two major 
PAK sites are already phosphorylated. 
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Figure 16.  Phosphorylation at both the major and minor sites of 
CaD22 decreased the affinity to Ca2+-calmodulin.  Binding was 
measured to CaD22 (open circles), CaD22 treated for 1.5 hours (dotted 
circles) and CaD22 treated for 20 hours with PAK (solid circles).  The data 
shown are from 4, 1 and 3 data sets, respectively.  The data were globally 
fit. The dotted lines represent 95% confidence intervals for each curve. 
Phosphorylation at the major sites (dotted circles) reduced the affinity from 
0.11 µM to 0.8 µM.  Additional phosphorylation to give 3.3 Pi/caldesmon 
reduced the affinity to 4.0 µM.  Inset: Plot of fraction of maximum binding 
against log[CaMfree].  The reaction buffer contained 10 mM MOPS pH 7.2, 
100 mM NaCl, 1 mM DTT, 2 mM CaCl2 at 20oC. CaD22 concentration was 
0.6 µM. 
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Figure 17. Effect of phosphorylation at the minor sites of CaD22AA (A) 
and CaD22DD (B).  CaD22 decreased calmodulin binding only if the major 
sites were negatively charged.  (A) Binding to CaDAA (open triangles, 4 
data sets) was identical to that of wild type (open circles, 4 data sets) and 
was unaffected by PAK treatment for 20 hours (solid triangles, 3 data sets).  
Phosphorylation of CaD22AA increased the affinity for Ca2+-calmodulin 
slightly (Kd decreased from 0.1 µM to 0.04 µM). The inset shows the 
fraction of maximum binding versus log[CaMfree].  (B) Substituting PAK 
phosphorylation sites with Asp, i.e. CaD22DD, (open triangles, 3 data sets) 
reduced the affinity of CaD22 to Ca2+-calmodulin to 1.15 µM compared with 
0.1 µM for wild type unphosphorylated (open circles, 4 data sets).  
Incubation of CaD22DD with PAK for 20 h (solid triangles, 3 data sets) 
caused a further reduction in its affinity of binding to calmodulin to 3.1 µM.  
The dotted lines represent 95% confidence intervals for each curve.  
Conditions are the same as in Fig. 16.  
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Effect of phosphorylation at the major and minor sites of CaD22 on 
the stoichiometry of binding to calmodulin. 
Phosphorylation of CaD22 may have altered the stoichiometry of 
binding to calmodulin in addition to decreasing the stability of the 
interaction. The stoichiometry was determined by repeating binding studies 
at CaD22 concentrations that exceeded the dissociation constant for the 
CaD22-calmodulin complex (Figure 18). As the concentration of calmodulin 
was increased a plateau of binding was reached at the same ratio of 
calmodulin to caldesmon for all of the CaD constructs. CaD22 formed 2:1 
complexes with Ca2+-calmodulin in agreement with previously reported data 
(Medvedeva et al. 1997). 
 
Analysis of the effect of Ca2+-calmodulin on the time course of 
phosphorylation of the minor sites. 
Because phosphorylation of caldesmon by PAK on the minor sites 
affected binding to Ca2+-calmodulin, we measured the effect of Ca2+-
calmodulin on the time course of phosphorylation of CaD22AA by PAK 
(Figure 19). In the presence of Ca2+-calmodulin (open squares) the 
phosphorylation of the minor sites was significantly slower that in the 
absence of Ca2+-calmodulin (open triangles). PAK did not phosphorylate 
Ca2+-calmodulin significantly (open circles).  
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Figure 18. The stoichiometry of CaD22 binding to calmodulin was 
altered neither by the DD mutation nor by PAK phosphorylation. 
CaD22 WT (open circles), WT-PAK (solid circles), DD (open triangles) and 
DD-PAK (solid triangles) were titrated with Ca2+-calmodulin. The CaD22 
concentration was 20 µM which is greater than the weakest dissociation 
constant (i.e. 4 µM for PAK phosphorylated CaD22). Under these 
conditions all added calmodulin bound to the CaD22 thus defining the 
stoichiometry under these conditions (2 mol CaD22 per mol calmodulin). 
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Figure 19. Ca2+-calmodulin binding decreased the rate of 
phosphorylation of the minor sites by PAK. Phosphorylation time 
courses were measured as described in Figure 2 with 0.5 µM CaD22AA 
and 2 µM Ca2+-calmodulin. Phosphorylation time courses of CaD22AA in 
the absence (open triangles) and in the presence of Ca2+-calmodulin (open 
squares) are shown. Ca2+-calmodulin was not appreciably phosphorylated 
by PAK (open circles). 
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Effect of phosphorylation at the major and minor sites of CaD22 on 
the ability of caldesmon to inhibit actin-activated myosin S1 ATPase 
activity. 
Phosphorylation of caldesmon reduces the ability of caldesmon to 
inhibit actin-activation of myosin S1 ATPase activity. We examined the 
contribution of the major and minor PAK phosphorylation sites on the 
inhibitory activity of CaD22.  Figure 20A shows the rate of actin activated 
ATPase activity as a function of wild type CaD22.  The CaD22 had 
produced inhibition that was typical of caldesmon.  In particular, 
tropomyosin markedly enhanced the inhibitory activity of CaD22.   
CaD22AA was expected to behave like wild type CaD22.  As shown 
in Fig 20B CaD22AA had the same inhibitory activity as wild type CaD22 
(Fig. 20B open triangles down and open circles).  The mutant designed to 
mimic phosphorylation at sites 672 and 702 was expected to have a 
diminished inhibitory activity.  However, CaD22DD (Fig. 20B open triangles 
up) had the same inhibitory activity as wild type and CaD22AA. After 
overnight incubation with PAK, the mutants as well as wild type CaD22 had 
similarly reduced inhibitory activities (Fig.20B, closed symbols).  Because 
the minor sites were not totally phosphorylated the total extent of reversal 
of activity was not determined.  These results suggested that the 
introduction of negative charges into the minor sites but not the major sites 
attenuated the inhibitory activity of CaD22.   
We also examined the effects of negative charges at sites 672 and 
702 in a larger caldesmon construct, CaD35.  That construct was 
previously characterized in our laboratory (Fredricksen et al. 2003). The 
inset in Fig. 20B shows that CaD35DD had the same ability to inhibit actin 
stimulated ATPase activity as CaD35WT. 
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Figure 20. Phosphorylation of the minor sites of CaD22 reduced the 
inhibition of actomyosin ATPase activity.  (A) Control showing actin-
activated S1-ATPase activity as a function of CaD22WT in the absence 
(open circles) and presence (solid circles) of smooth muscle 
tropomyosin.  Concentrations of actin, smooth muscle tropomyosin and 
myosin S1 were 10 µM, 2.2 µM and 0.1 µM, respectively. The final 
solution composition was 1 mM ATP, 3 mM MgCl2, 31 mM NaCl, 10 mM 
imidazole pH 7.0 at 25°C. (B) Actin-activated S1-AT Pase as a function 
of phosphorylated and unphosphorylated CaD22WT (circles), CaD22DD 
(triangles up) and CaD22AA (triangles down).  Open symbols show the 
effect of unphosphorylated CaD22 whereas solid symbols show the 
corresponding species after 20 hour treatment with PAK.  The inset 
shows actin-activated S1-ATPase as a function of CaD35WT and 
CaD35DD.  
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Analysis of the calmodulin dependencies of ATPase activities of 
unphosphorylated and phosphorylated caldesmon. 
The results of Figures 16 and 20 indicate that phosphorylation of 
CaD22 may have more significant effects on ATPase activity in the 
presence of Ca2+-calmodulin.  That possibility was investigated by 
comparing the calmodulin dependencies of ATPase activities of 
unphosphorylated and phosphorylated CaD22.  Ca2+-calmodulin was 
effective in reversing CaD22WT inhibition of actomyosin ATPase (Figure 
21, open circles), but was not able to effectively reverse the inhibition by 
CaD22DD in which only the major PAK sites were negatively charged 
(open triangles).  That is, when the major PAK sites were negatively 
charged caldesmon was inhibitory even in the presence of Ca2+-calmodulin. 
When CaD22 was phosphorylated at both the major and minor sites with 
PAK there was less inhibition of ATPase activity in the absence of Ca2+-
calmodulin and Ca2+-calmodulin had little effect on the degree of inhibition. 
 
Identification of the minor PAK phosphorylation sites in CaD22. 
The additional sites of phosphorylation of CaD22 were identified by 
mass spectrometry. CaD22WT and CaD22WT incubated with PAK for 20 
hours were digested with modified trypsin and analyzed by LC-MS/MS, as 
described in Materials and Methods. The phosphorylated peptides and 
corresponding non-phosphorylated peptides were compared. The 
phosphorylated residues corresponded to Thr627, Ser631, Ser635 and 
Ser642. Phosphorylated Thr627 and Ser631 were the most abundant. The 
localization of these sites relative to other known phosphorylation sites is 
shown in Figure 22. 
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Figure 21. Ca2+-calmodulin has different effects on the inhibitory 
activities of unphosphorylated and highly phosphorylated CaD22.  
Shown are unphosphorylated CaD22WT (open circles), CaD22WT-PAK 
incubated with PAK for 20 hours (solid circles) and CaD22-DD (open 
triangles). Conditions are the same as in Fig. 20 except [CaD22] was held 
constant at 1.1 µM. 
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Figure 22. Phosphorylation sites on CaD22. All phosphorylation sites are 
in bold.  Major PAK kinase sites are in square brackets.  Minor PAK sites 
are in parentheses.  MAPK sites1, Calmodulin kinase II sites2, cdc2 kinase 
sites3 and PKC sites4 are indicated with superscripts as shown.  The 
tropomyosin-binding region has a single underline.  The calmodulin-binding 
regions have a double underline. The residue numbers at the beginning 
and at the end of the sequence are in curly brackets. 
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{563}MKEEIERRRAEAAEKRQKVPEDGVSEEKKPFKCFS3PKGSS2,4LKIEERAEFLNK 
 
SAQKSGMKPAHT(T)AVV(S)KID(S)2RLEQYT(S)AVVGNKAAKPAKPAASDLPVPAE 
 
GVRNIK[S]MWEKGNVFSS3PGGTGT3PNKETAGLKVGVS[S]RINEWLTKT3PEGNKS1,3 
 
PAPKPSDLRPGDVSGKRNLWEKQS2,4VEKPAASSSKVTATGKKSETNGLRQFEKEP{771} 
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Analysis of the contribution of one of the minor PAK sites, Thr627. 
It is not clear whether all of the minor sites, a combination of these 
sites or just one of them is responsible for the observed functional effects. 
We modified Thr 627 to Asp in CaD22DD to mimic the phosphorylated 
state of that minor site and the 2 major sites  
The sequences of the DNA and mutant were verified.  The observed 
mass difference between the triple mutant and the wild type caldesmon 
(68) agreed with the calculated difference (70).  
Figure 23 shows the effect of phosphorylation of Thr627 and  the 
major sites on binding to  Ca2+-calmodulin, The affinity of the triple mutant 
for Ca2+-calmodulin was weaker than that for  CaD22WT (open circles), but 
stronger than  that of CaD22-PAK (dashed line). The binding affinity of the 
triple mutant was similar to that of CaD22DD that has negative charges on 
the major sites only. Treatment of the triple mutant with PAK reduced the 
binding affinity, bringing it close to that of the phosphorylated wild type 
CaD22. This suggests that the residue Thr627 by itself does not affect 
Ca2+-calmodulin binding to caldesmon phosphorylated on the major sites. 
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Figure 23. Aspartate substitution at Thr627 in combination with 
aspartate substitutions at the major sites did not affect calmodulin 
binding. Calmodulin binding curves for wild type (open circles, 4 data 
sets), triple mutant (open diamonds, 3 data sets) and triple mutant after 20 
h PAK treatment (solid diamonds, 2 data sets) are shown with their 95% 
confidence limits (dotted lines).  Dissociation constants for CaD22DD and 
the triple mutant were 1.15 µM and 1.64 µM, respectively.  The binding 
curve for the triple mutant was similar to that of CaD22DD (short dashed 
line).  PAK phosphorylation of the triple mutant reduced the affinity to 4.5 
µM which is similar to that observed for CaD22WT-PAK (long dashed line). 
Conditions are the same as in Fig. 16.   
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Because of the role of phosphorylation of the minor sites in controlling 
inhibition of ATPase activity by caldesmon (Figure 20) we explored the 
effects of the triple mutant on the ATPase activity of caldesmon. The triple 
mutant (Figure 24, open diamonds) had the same inhibitory activity as the 
wild type CaD22 (open circles) and did not exhibit the reduced inhibitory 
activity, as the wild type phosphorylated by PAK on both the major and the 
minor residues (Figure 20B). 
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Figure 24. Aspartate substitution at Thr627 in combination with 
aspartate substitutions at the major sites did not affect the inhibition 
of actomyosin ATPase activity by caldesmon. Actin-activated S1-
ATPase rates are shown as a function of concentrations of 
unphosphorylated CaD22WT (open circles) and the triple mutant (open 
diamonds).  Conditions are the same as in Figure 20.  
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Discussion 
PAK kinase phosphorylates caldesmon at Ser 672 and Ser 702 
(Foster et al. 2000).  Phosphorylation at these sites reduces binding to 
calmodulin and gives a partial reversal of the inhibitory action of caldesmon 
on actomyosin ATPase activity (Foster et al. 2000; Eppinga et al. 2006).  
We confirmed the effect of phosphorylation on calmodulin binding but we 
observed little change in ATPase inhibitory activity.  Phosphorylation at 
Thr627, Ser631, Ser635, and Ser642 further weakened calmodulin binding 
and partially reversed ATPase activity.  Serine residues at sites 672 and 
702 were substituted with either aspartic acid (CaD22DD) or alanine 
(CaD22AA) to simulate the phosphorylated and non-phosphorylated states, 
respectively.  This procedure permitted us to investigate the relationship 
among the major (672, 702) and minor (627, 631, 635, and 642) sites of 
phosphorylation.   
In the case of phosphorylated wild type CaD22 the affinity for Ca2+-
calmodulin decreased after further incubation with PAK.  That further 
incubation was accompanied by phosphorylation at the minor sites.  To 
insure that the further reduction in affinity was not linked to an increase in 
phosphorylation of the major sites we utilized CaD22DD.  The affinity of 
CaD22DD for Ca2+-calmodulin was about 10% of that observed with wild 
type CaD22.  Incubation of CaD22DD with PAK caused a further reduction 
in affinity for Ca2+-calmodulin to about 3% of the wild type affinity. The 
effect of phosphorylation of the minor sites on Ca2+-calmodulin binding was 
dependent on the prior phosphorylation of the major sites.  Replacement of 
serine residues 672 and 702 by alanine had no effect on Ca2+-calmodulin 
binding compared to wild type CaD22.  Incubation of CaD22AA with PAK 
did not weaken Ca2+-calmodulin binding although the minor sites became 
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phosphorylated.  That is, the only effect of phosphorylation of the minor 
sites on Ca2+-calmodulin binding is to enhance the effect of phosphorylation 
at the major sites.   
The effect of phosphorylation at the major PAK sites on weakening 
Ca2+-calmodulin binding is easy to rationalize because those sites are 
adjacent to the Ca2+-Calmodulin binding region of calmodulin.  However, 
the minor phosphorylation sites are about 30 residues upstream from the 
closest known calmodulin binding site (Fig. 22).  One hypothesis for such a 
change is that calmodulin binding induces structural changes in the natively 
unfolded C-terminal region of caldesmon. Flexation of caldesmon peptide 
chain in the C-terminal region resulting in multiple contacts with calmodulin 
has been suggested earlier (Medvedeva et al. 1997).   
We explored the effect of calmodulin binding on the time course of 
PAK phosphorylation of CaD22AA that has the two major sites blocked. 
Phosphorylation of the minor sites was significantly slower in the presence 
of Ca2+-calmodulin than in the absence of Ca2+-calmodulin. This indicates 
that Ca2+-calmodulin binding to caldesmon impedes PAK access to the 
minor sites.  
Foster et al. (2000) found that PAK phosphorylation of intact 
caldesmon attenuated the inhibition of actin-S1 ATPase.  We observed 
attenuation of the inhibitory activity of CaD22 only under conditions where 
PAK phosphorylated the minor sites of CaD22.  The phosphomimetic 
mutant of the major sites, CaD22DD, had the same inhibitory activity as 
CaD22 and CaD22AA.  Furthermore, introducing negative charges at sites 
672 and 702 had no effect on the inhibitory activity of the larger caldesmon 
construct, CaD35.   
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Prolonged incubation of CaD22WT, CaD22DD and CaD22AA with 
PAK did attenuate their inhibitory activities and all to the same extent.  That 
is, phosphorylation of the minor sites of our construct was necessary for 
reversal of inhibitory activity irrespective of the state of residues 672 and 
702.   
Our results differ from those of Eppinga et al. (2006) who found 
complete reversal of inhibitory activity when the major PAK sites were 
mutated to glutamate residues.  They reported that the phosphomimetic 
CaD39-PAKE had no inhibitory activity toward HMM ATPase at all.  We do 
not know the reason for our different observations.  It is clear though that 
phosphorylation of the minor sites does reduce the inhibitory activity of 
caldesmon. 
PAK phosphorylation leads to a direct reduction in inhibitory activity of 
caldesmon.  PAK phosphorylation also indirectly increases inhibitory 
activity by weakening binding to Ca2+-calmodulin.  Fig. 21 shows that the 
net activity depends on the concentration of Ca2+-calmodulin and the 
number of caldesmon sites that are phosphorylated.  For all caldesmon 
species examined the acto-S1 ATPase rates increased with increasing 
calmodulin concentrations.  The rates of ATP hydrolysis in the presence of 
CaD22DD (mimicking phosphorylation of the major sites) were lower than 
those of wild type at all calmodulin concentrations.  Caldesmon that was 
phosphorylated at the minor and major sites had higher activity than wild 
type at low calmodulin concentrations but the difference was abolished at 
high calmodulin concentrations.   
It is interesting that a caldesmon mutant defective in Ca2+-calmodulin 
binding sites fails to be recruited to podosomes, and fails to suppress the 
podosome formation.  Selective control of caldesmon phosphorylation may 
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produce similar changes in calmodulin binding and produce similar cellular 
effects.   
The results presented in this chapter suggest that the two main 
regulators of caldesmon in the cell, Ca2+-calmodulin and phosphorylation, 
are not redundant mechanisms that substitute for one another. PAK 
phosphorylation and calmodulin cause different structural effects and allow 
smooth muscle contractility to be fine-tuned to the immediate needs of the 
cell.  
Phosphorylation of the minor sites of caldesmon by PAK was very 
slow.  It is possible that binding to some target molecule can alter the ability 
of the minor caldesmon sites to become phosphorylated.  Molecular 
crowding in vivo may drastically change binding affinities of natively 
unfolded proteins; hence PAK might be more efficient in crowded 
environment (Yarmola et al, 2010). It is also possible that another kinase is 
able to rapidly phosphorylate the minor sites of caldesmon. To facilitate 
identification of possible kinases we identified the minor PAK 
phosphorylation sites of caldesmon.  Those sites were Thr627, Ser631, 
Ser635 and Ser642.  The location of those sites within CaD22 is shown in 
Fig. 22.  Semi-quantitative analysis of the extracted ion chromatograms 
showed that Thr627 and Ser631 carried the greatest amounts of 
phosphate, while Ser642 had the least amount of phosphate. All 4 sites are 
clustered together, and the 3 most highly phosphorylated residues are 
located within the tropomyosin-binding region (residues 524-577and 579-
635 (Wang et al. 1991)).  Despite this location the attenuation of caldesmon 
inhibition did not require tropomyosin.   Phosphorylation at the minor sites 
reduced the inhibitory activity of caldesmon in the absence of tropomyosin 
but to a lesser extent (data not shown).   
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If phosphorylation of the minor PAK sites (Thr627, Ser631, Ser635 or 
Ser642) serve a physiological role they are likely to be phosphorylated 
more rapidly than observed here.  These sites could be better substrates 
for other kinases or phosphorylation may be linked to binding of caldesmon 
to a particular ligand.   
Interestingly, one of the most heavily phosphorylated minor sites, 
Thr627, is adjacent to a myosin light chain kinase (MLCK) site, Thr626 
(unpublished data from another lab). We investigated the properties of the 
triple phospho-mimicking mutant in which the major sites and one of the 
minor sites, Thr627, were mutated to Asp. We found that Thr627 by itself 
was unable to reproduce the effect of phosphorylation on all four minor 
sites, i.e. the triple mutant was unable to further reduce the binding affinity 
to Ca2+-calmodulin and disinhibit the actin-activated S1-ATPase. That 
suggests that MLCK and Thr627 cannot be the kinase and the 
phosphorylation site that conveys the observed functional effects in the cell. 
Another candidate is Ser635 that is a known substrate for Ca-
Calmodulin kinase II (Ikebe and Reardon, 1990).  The additive effects seen 
here may be an indication that caldesmon is coordinately regulated at 
several levels. 
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SUMMARY AND UNANSWERED QUESTIONS 
Smooth muscle contraction may be altered through regulation of actin 
by actin-binding proteins. Interestingly, many actin-binding proteins contain 
long regions of intrinsic disorder (Permyakov et al. 2003; Czisch et al. 
1993; Kim et al. 2000). It is not entirely clear yet how the disordered 
regions contribute to the regulation of actin. We wished to determine 
whether altering the unfolded regions of actin-binding proteins by a ligand 
binding or phosphorylation modifies their structures and functions. 
 First part of this project demonstrates that yet another actin-binding 
protein, fesselin, is natively unfolded. This information can be used as a 
guide for understanding the function of fesselin.  
Fesselin is localized in dense bodies that are equivalent to Z-lines of 
skeletal muscle, where the ends of thin filaments from the adjacent 
sarcomeres overlap. Fesselin, as a natively unfolded protein, has many 
binding partners. Hence we speculate that fesselin works by organizing 
myofilaments into an ordered structure. It would be interesting to test this 
hypothesis in the cell by observing the effect of fesselin knockdown on the 
structural integrity of dense bodies in the cell. 
Natively unfolded proteins are often involved in signaling and 
transcriptional regulation. Fesselin is a natively unfolded protein that 
shuttles between the nucleus and the Z-disks of myocytes depending on its 
differentiation stage and stress conditions, such as an increase in 
mechanical load (Weins et al, 2001).  Hence fesselin might be involved in 
signal transduction leading to changes in gene expression between the 
dense bodies and the nucleus. Nuclear translocation of fesselin is 
regulated by phosphorylation (Faul et al. 2007). It would be interesting to 
check for changes in phosphorylation of fesselin upon increased force 
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applied to a smooth muscle. Uncovering such regulatory mechanism could 
potentially lead to a means of maintaining a healthy muscle tone. 
 Second part of this work demonstrated that another major actin-
binding natively unfolded protein caldesmon that shares many properties 
with fesselin is regulated by Ca2+-calmodulin and phosphorylation by PAK 
kinase through different mechanisms. We discovered a novel regulatory 
region between the residues 627-642 in the unfolded caldesmon C-
terminus. Phosphorylation of this region alters both the ability of caldesmon 
to inhibit actomyosin ATPase and the interactions between caldesmon and 
Ca2+-calmodulin. We identified four minor residues slowly phosphorylated 
by PAK. One of the still to be answered questions is which of the minor 
phosphorylation sites is responsible for the observed functional effects. 
Another unanswered question is whether or not this region is 
phosphorylated in vivo.  
PAK kinase is slow to phosphorylate this region in vitro, but if the 
conformation of caldesmon is altered in vivo by binding to a target molecule 
or by molecular crowding, PAK might be more efficient in the cell. 
Alternatively, this region may be rapidly phosphorylated by a kinase other 
than PAK. Further research is needed to identify the kinase that 
phosphorylates the region between the residues 627-642, if indeed it could 
be phosphorylated in the cell. 
The second part of the project also demonstrated that different 
combinations of phosphorylation state of the region between residues 627-
642 of caldesmon, phosphorylation state of the major PAK sites (Ser 672 
and Ser 702) and concentration of free calmodulin and free Ca2+ allow cells 
to “choose” between the regulatory modes with either high or low ATPase 
activity that can or cannot be altered by Ca2+-calmodulin binding. 
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We demonstrated that the regulation of caldesmon is fairly 
complicated. Multiple kinases have been shown to phosphorylate 
caldesmon. Researchers have been focusing so far on the effects of one or 
another kinase on caldesmon function, and there has been an extensive 
discussion about which kinase is the most important in the regulation of 
caldesmon (Gorenne et al. 2004; Redwood et al. 1993; Childs et al. 1992). 
This work suggests that the signaling by several kinases might converge on 
caldesmon. Hence an approach is needed to look for global effects of 
caldesmon phosphorylation. 
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CHAPTER IV: MATERIALS AND METHODS 
Protein preparation 
Actin and myosin were isolated from rabbit back muscle (Spudich and 
Watt, 1971, Kielley and Harrington, 1960). Myosin subfragment 1 was 
made by digestion of myosin with chymotrypsin, for 10 minutes at 250C. 
The digestion product subfragment 1 (S1) retains the ability to bind to actin 
and hydrolyze ATP. (Weeds and Taylor, 1975).  
Recombinant (Arabidopsis) calmodulin (pRZ72; a gift from Dr. Ralf 
Zielinski, University of Illinois at Urbana-Champaign, Urbana, IL, U.S.A.) 
was expressed in Escherichia coli BL21 cells and prepared as described by 
(Pedgio and Shea 1995).   Smooth muscle tropomyosin was isolated from 
turkey gizzards (Bretcher 1984). 
Fesselin was purified from turkey gizzards using the method of 
Leinweber et al. (1999).  The 22 kDa C-terminal fragment of caldesmon, 
the 35 kDa C-terminal fragment of caldesmon, double alanine and double 
aspartic acid mutants were expressed in Escherichia coli and purified 
according to Fredricksen et al. (2003).  p21-activated kinase (GST-mPAK3, 
a gift from Dr. Alan Mak, Queen's University, Kingston, ON. U.S.A) was 
expressed in Escherichia coli BL21 cells and prepared as described before 
(Van Eyk et al. 1998). 
The concentrations of the different CaD22 fragments and fesselin 
were determined by the Lowry assay with bovine serum albumin as a 
standard.  The concentrations of other proteins were determined by 
absorbance at 280 nm, corrected for scattering at 340 nm, using the 
following extinction coefficients E2800.1%: actin, 1.15, smooth muscle 
tropomyosin, 0.22, myosin S1, 0.75, and calmodulin, 0.19. The molecular 
masses assumed for the key proteins were myosin S1, 120000 Da, actin, 
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42000 Da, smooth muscle tropomyosin, 68000 Da, CaD22, 22000 Da, 
calmodulin, 16800 Da. 
 
Stokes Radius Determination 
 Fesselin, Caldesmon 22, S1 and a series of known globular proteins 
were chromatographed on two Bio-Sil TSK-400 columns (80 x 7.8 nm and 
600 x 7.5 mm) in tandem in a buffer containing 20 mM MOPS, pH 7.0, 0.2 
M NaCl, 2 mM EGTA on a Waters 600E HPLC.  Peak absorbances were 
monitored with a Waters 441 UV detector at 254 nm.  The molecular weight 
of each substance was determined by laser light scattering on a Wyatt mini 
Dawn device with a Wyatt Optilab Rex refractive index detector. Calibration 
standards included thyroglobulin (Rs = 8.5 nm), alcohol dehydrogenase (Rs 
= 4.6 nm), bovine γ-globulin (Rs = 4.81 nm), myosin S1 (Rs = 4.8 nm, 
indicated by the arrow), chicken ovalbumin (Rs = 3.05 nm), carbonic 
anhydrase (Rs = 2.4 nm), equine myoglobin (Rs = 2.07 nm) and cytochrome 
C (Rs = 1.64 nm). The elution volume of proteins of known Stokes radius 
was used to determine the Stokes radius of fesselin, Cad22 and S1.  
 
The relationship between the Stokes radius and the logarithm of 
molecular weight is given by the following equation: 
 
log(Rs) = a + b*log(M),      (Equation 1) 
 
where a and b are the constants depending on the conformational state of 
a given protein (native, molten globule, premolten globule, natively 
unfolded coil, etc.) (Uversky 2002a). 
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Fluorescence measurements 
The exposure of tryptophan residues to the solution and Ca2+-
calmodulin binding ware determined by changes in intrinsic tryptophan 
fluorescence of fesselin and CaD22.  Fluorescence measurements were 
made on an Aminco Bowman II Luminescence Spectrometer (Thermo 
Electron Corp., Madison WI USA) having the cell compartment maintained 
at 20oC with a circulating bath, in a buffer containing 10 mM MOPS pH 7.2, 
100 mM NaCl, 1 mM dithiothreitol, 2 mM CaCl2.  Tryptophan fluorescence 
was measured with excitation and emission monochomators set to 295 nm 
and 340 nm, respectively. The absorbance of the protein solutions at the 
excitation wavelength was always kept low, so that inner filter effects could 
be neglected. Titrations with quenchers were done by adding small 
volumes of 5.6 M acrylamide. 10 minutes were allowed to pass before each 
measurement.  The total dilution of the sample over the course of the 
titration was less than 10%.  Spectra were corrected for the fluorescence 
contribution from calmodulin in the same buffer solution and for wavelength 
dependent lamp output.  Because calmodulin lacks tryptophan residues, 
the correction for calmodulin was less than 5%. 
Fluorescence quenching studies were analyzed using the Stern-
Volmer equation for dynamic and static quenching: 
 
F0/F = 1 + (KD + KS)*[Q] + KD*KS* [Q]2   (Equation 2) 
 
where F0 and F are the fluorescence intensities in the absence and 
presence of quencher, respectively; KD and KS are the dynamic and static 
Stern-Volmer quenching constants, Q is the concentration of the quencher. 
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 Calmodulin binding data were analyzed using SigmaPlot 11.2 
software (Systat Software, INC. San Jose CA, USA). The multiple sets of 
binding data were fitted to a rectangular hyperbola and the Kd values were 
extracted: 
 
Y = (Bmax*X)/(Kd + X)   (Equation 3) 
 
where Bmax  is a number of binding sites; Kd is an equilibrium dissociation 
constant. 
The 95% confidence intervals (the region of uncertainties in the predicted 
values over a range of values for the independent variable) were also 
estimated using SigmaPlot 11.2. 
 
Circular Dichroism 
Circular dichroism spectra were obtained with JASKO J-810 
spectrometer. Spectra were recorded using 0.01-cm pathlength cell at 
room temperature (pH titration experiment) in a buffer containing 50 mM 
potassium chloride and 2 mM sodium phosphate. Spectra of appropriate 
buffers were recorded and subtracted from the protein spectra. For all 
spectra, the average of 8 scans was obtained. The reliability of the data 
was monitored by recording high tension voltage. The difference between 
absorbance of left circularly polarized and right circularly polarized light 
(∆A) was measured, and mean residue ellipticity (M.R.E.) was calculated 
as described below: 
 
M.R.E = 3298.2*∆A/(C*l*n)            (Equation 4) 
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Where C is the molar concentration, l is the path length in 
centimeters, n is the number of residues in the protein. 
 
Primary Structure Analysis of fesselin  
Sequence information was obtained from GenBank ABU55374.1 for 
fesselin from turkey meleagris gallopavo
 
(Schroeter et al. 2008).  Sequence 
information was analyzed using the PONDR (Predictor of Natural 
Disordered Regions) program and Network Protein Sequence Analysis web 
server. (Combet et al. 2000). 
 
Phosphorylation of Caldesmon 
CaD22 (generally 1 mg/ml) was phosphorylated by constitutively 
active GST-mPAK3 (~10 µg/µl).  All the phosphorylation reactions were 
carried out at 250C for indicated time, in 20 mM Tris pH 7.5, 100 mM NaCl, 
5 mM MgCl2, 0.5 mM dithiothreitol. The reactions were initiated by addition 
of 1 mM ATP. Phosphorylated protein was used for experimental purposes 
immediately.  Phosphorylation times are given in the text.  
 
Detection of phosphorylation  
The extent of phosphorylation was determined by Non-equilibrium 
isoelectric focusing gel electrophoresis (NEIEF) as described by Kobayashi 
et al (2005). Gels contained 8 M urea, 5% acrylamide, 0.8% ampholyte pH 
3.0-10.0 and 1.2% ampholyte pH 8.0-10.0 (BioRad, CA). Sample loading 
buffer contained 8 M urea, 10mM EDTA and 1% ampholyte pH 3.0-10.0. 
The running times were 30 minutes at 100 V, 40 minutes at 200 V and 20 
minutes at 500 V. The gels were soaked in fixing solution containing 10% 
methanol and 5% acetic acid, and then stained with Coomassie Blue stain.  
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Phosphorylation time course measurements  
Time courses of phosphorylation were determined by measuring the 
incorporation of 32P into caldesmon fragments at various time intervals with 
a filter paper assay (Conti and Adelstein, 1991). Caldesmon fragments 
were phosphorylated by PAK at 25°C in 20 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 5 mM MgCl2, 1 mM dithiothreitol and 1 mM 32P-ATP (4*105 
cpm/nmol). Aliquots were drawn at different times after initiation of 
phosphorylation and placed onto Whatman grade 3 filter circles (2.3 cm 
diameter).  Filters were dropped immediately into ice-cold 10% TCA, 8% 
sodium pyrophosphate (w/v), followed by 3 subsequent washes for 10-15 
minutes with 10% TCA, 2% sodium pyrophosphate at room temperature.  
The filters were then washed in 95% ethanol and finally in acetone.  The 
32P activity of the filters was determined by liquid scintillation counting. 
 
 Identification of the phosphorylation sites   
The sites of phosphorylation were identified by mass spectrometry.  
The CaD22 protein bands were excised from SDS gels, reduced, alkylated 
and digested with modified trypsin (Promega).  The peptides were analyzed 
by LC-MS/MS using capillary HPLC with a 75 µm nanocolumn and a 
Thermo Electron LTQ quadrapole ion trap mass spectrometer.  The 
resulting masses and spectra were searched against a database using 
TurboSequest (Chittum et al. 1998; Eng et al. 1994) with the Proteomics 
Browser interface (William Lane, Harvard Microchemistry and Proteomics 
Analysis Facility).  Extracted Ion Chromatograms of full MS scan were 
performed on the m/z values that match the phosphorylated peptides and 
corresponding non-phosphorylated peptides using a mass error window of 
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±5ppm.  The peptide identities of integrated peaks were verified based on 
retention times of the MS/MS spectra. Mass Spectral analysis was 
performed at the Wistar proteomics facility, Philadelphia, PA.   
 
ATPase Rate measurements 
Rates were determined by measuring the time dependence of 32Pi 
formation from γ32P-labeled ATP at 25ºC.  Concentrations of actin, smooth 
muscle tropomyosin and myosin S1 were 10 µM, 2.2 µM and 0.1 µM, 
respectively. The final solution composition was 1 mM ATP, 3 mM MgCl2, 
31 mM NaCl, 10 mM imidazole pH 7.0. The reaction volume was 1 ml. 
Aliquots of 0.2 ml were removed at different time points and quantified as 
described earlier (Chalovich and Eisenberg, 1982). A minimum of 4 time 
points were taken over the 10-15 minute period to establish the rate. The 
measured rates are the initial rates since the production of 32P was linear 
over this time period. 
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APPENDIX I. AN ATTEMPT TO EXPRESS A 10 KD FRAGMENT OF 
FESSELIN 
Identification of Ca2+-Calmodulin binding site in the sequence of fesselin 
For our analysis we used the sequence of fesselin from turkey 
meleagris gallopavo
 {GenBank: ABU55374.1} (Schroeter et al. 2008). 
It is possible that fesselin contains several calmodulin-binding sites. 
In fact, a number of data produced in our lab could not be explained by the 
assumption that fesselin binds only 1 calmodulin molecule (Schroeter and 
Chalovich, 2004).  
To determine where the possible calmodulin-binding sites may be, 
the sequence of fesselin was submitted to the program “Calmodulin target 
database”. This program compares a submitted sequence to the known 
calmodulin-binding sequences and also analyzes the sequence for possible 
binding sites based on the evaluation criteria, such as hydropathy, alpha-
helical propensity, residue weight, residue charge, hydrophobic residue 
content, helical class and occurrence of particular residues. As an output, 
the program gives each amino acid in the sequence a score. The higher is 
the score of a particular stretch of amino acids, the greater is the probability 
of this stretch to bind Ca2+-calmodulin. Zero scores indicate the unlikely 
involvement in the formation of a calmodulin-binding site. 
No matches to the sequences known to bind calmodulin were found.  
During the analysis for putative binding sites, several sites demonstrated a 
high score indicating possible locations of a calmodulin-binding site (Figure 
25). 
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Figure 25. Analysis of the sequence of fesselin using the program 
“Calmodulin target database”. High scores indicate the possible location of 
a calmodulin-binding site. 
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....1 …….MGTGDYICIA   MSGGAPWGFR  LQGGKEQKQP  LQIAKVRNKS  KAAKAGLCEG 
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..... 0000000000 0000000000 0000000000 0000000000 0000000000 
 
.1251 YNPQPKGWRR PT 
..... 0000000000 00 
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Also during earlier experiments performed in our lab, a fragment of 
fesselin that bound to actin and calmodulin was generated. By MALDI-TOF 
fingerprint analysis, it was determined to represent the amino acids 831 to 
962 of fesselin sequence from meleagris gallopavo
 {GenBank: 
ABU55374.1}.  
The program PONDR predicts a short dip below the threshold of 0.6 
with the extensive flanking disordered regions in the area of amino acids 
865-884 corresponding to a predicted calmodulin-binding site (Figure 26). 
This correlates perfectly with the generalizations established for α-MoREs 
(Oldfield et al. 2005), short regions that undergo coupled binding and 
folding within a longer region of disorder. 
We chose to clone and express a fragment containing amino acids 
865 to 884 (Figure 27). This predicted Ca2+-calmodulin binding site scored 
low according to the program “Calmodulin target database”, but the 
experimental evidence of binding overrode a theoretical prediction.  
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Figure 26 Possible location of a MoRE in the sequence of fesselin as 
predicted by PONDR. 
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Figure 27 Diagram showing the amino acid sequence for the fesselin 10 
kD fragment  
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MRGKGAQ LFARRHSRME KYVVDSETVQ ANMARASSPT PSLPASWKYS 
SNVRAPPPVA YNPIHSPSYP PAATKPFPKS TAATKNTKRK PKKGLNALDI 
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Results 
No expression of the fesselin 10kD fragment subcloned into pSBETA 
vector in E.coli 
cDNA sequence of 10 kD fesselin fragment was subcloned into 
pSBET-A vector and overexpressed in E.coli. The cells were allowed to 
grow for different times varying form 1 hour to 20 hours. The fragment 
could not be expressed to a detectable amount (Figure 28). Other 
conditions tested include: LB or YTA expression medium with or without 
2% glucose; expression temperature 370C or 200C; concentration of IPTG 
used to induce expression 0.1-0.4 mM. 
 
No expression of a Glutathione-S-Transferase (GST)-fused or an 
intein-fused 10kD fragment of fesselin in E.coli 
The cDNA sequence corresponding to the 10 kD fesselin fragment 
was subcloned into pGEX-3X vector and into pTYB1 vector and 
overexpressed in E.coli both as a GST-fusion and an intein-fusion protein, 
respectively. The cultures were grown at various temperatures until their 
absorbance at 600 nm reached 0.6. At this point expression of fesselin 
fragment was induced by adding different concentrations of IPTG. The cells 
were allowed to grow for different times and harvested. The fragment could 
not be detected in either case (Figure 29). Conditions tested include: LB or 
YTA expression medium with or without 2% glucose; growth temperatures 
370C, 200C or 100C; concentration of IPTG used to induce expression 0.1-
0.4 mM; incubation time after induction 1 hour to 20 hours. 
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Figure 28. SDS-gel showing no overexpression of 10kD fesselin fragment 
in E.coli. Lane A – molecular weight standards. Lane B – expression of an 
empty vector. Lanes C-F – no expression of the fesselin fragment. The 
arrow indicates the expected position of the 10kD fragment. 
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FIGURE 29. SDS-gel showing no overexpression of GST-fused 10kD 
fesselin fragment in E.coli Lane A – expression of GST in E.coli. Lanes B-E 
– no expression of GST-Fesselin fusion protein under different conditions. 
The oval arrow indicates the position of GST tag, the diamond arrow 
indicates the expected position of the fusion protein. 
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